HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Q4

This article was originally published in The Rose Sheet

Executive Summary

Direct seller's net beauty sales grew 15% in the fourth quarter to $2.2 bil., driving overall 13% jump in revenue to $3.2 bil., company reported Feb. 4. Net income for the quarter grew 16% to $269.4 mil. On a regional basis, due largely to favorable currency valuations, revenue in the quarter climbed in Latin America; Central and Eastern Europe; Western Europe, Middle East and Africa; and Asia-Pacific. However, revenue declined in China (8%) and North America (7%), the latter impacted by lower consumer spending and double-digit declines in sales in the fashion and home categories. CFO Charles Cramb noted during a Feb. 4 conference call with investors that the recent devaluation of Venezuela's currency will have an $85 mil. unfavorable impact on the company's operating profit in 2010. For full-year 2009, revenue dipped 3% to $10.3 bil. and profit tumbled 29% to $625.8 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016711

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel